The average one-year price target for AB Science (ENXTPA:AB) has been revised to €4.31 / share. This is an increase of 22.25% from the prior estimate of €3.53 dated September 27, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of €3.49 to a high of €5.25 / share. The average price target represents an increase of 267.51% from the latest reported closing price of €1.17 / share.
What is the Fund Sentiment?
There are 1 funds or institutions reporting positions in AB Science. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to AB is 0.00%, an increase of 5.46%. Total shares owned by institutions decreased in the last three months by 41.42% to 1K shares.
What are Other Shareholders Doing?
SPEU - SPDR(R) Portfolio Europe ETF holds 1K shares representing 0.00% ownership of the company. In its prior filing, the firm reported owning 2K shares , representing a decrease of 70.71%. The firm increased its portfolio allocation in AB by 5.46% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.